A type of?drugs made of?protein. These?drugs usually have large molecular weight with?proteincharacteristics.
This report aims to provide a comprehensive presentation of the global market for Protein Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Drugs. This report contains market size and forecasts of Protein Drugs in global, including the following market information:
Global Protein Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Protein Drugs market was valued at US$ 274630 million in 2022 and is projected to reach US$ 439490 million by 2029, at a CAGR of 6.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antibody Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Protein Drugs include Eli Lilly, Abbott Laboratories, UCB Group, Schering-Plough Corporation, Genentech, Johnson?Johnson, Bristol-Myers Squibb, Novo Nordisk and Biogen Idec, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Protein Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Protein Drugs Market Segment Percentages, by Type, 2022 (%)
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
Global Protein Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Protein Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Other
Global Protein Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Protein Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Protein Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson?Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein Drugs, market overview.
Chapter 2: Global Protein Drugs market size in revenue.
Chapter 3: Detailed analysis of Protein Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Protein Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Protein Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Protein Drugs Overall Market Size
2.1 Global Protein Drugs Market Size: 2022 VS 2029
2.2 Global Protein Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Protein Drugs Players in Global Market
3.2 Top Global Protein Drugs Companies Ranked by Revenue
3.3 Global Protein Drugs Revenue by Companies
3.4 Top 3 and Top 5 Protein Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Protein Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Protein Drugs Players in Global Market
3.6.1 List of Global Tier 1 Protein Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Protein Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Protein Drugs Market Size Markets, 2022 & 2029
4.1.2 Antibody Drugs
4.1.3 Peptide Hormones
4.1.4 Blood Products
4.1.5 Enzymes
4.2 By Type - Global Protein Drugs Revenue & Forecasts
4.2.1 By Type - Global Protein Drugs Revenue, 2018-2023
4.2.2 By Type - Global Protein Drugs Revenue, 2024-2029
4.2.3 By Type - Global Protein Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Protein Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Protein Drugs Revenue & Forecasts
5.2.1 By Application - Global Protein Drugs Revenue, 2018-2023
5.2.2 By Application - Global Protein Drugs Revenue, 2024-2029
5.2.3 By Application - Global Protein Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Protein Drugs Market Size, 2022 & 2029
6.2 By Region - Global Protein Drugs Revenue & Forecasts
6.2.1 By Region - Global Protein Drugs Revenue, 2018-2023
6.2.2 By Region - Global Protein Drugs Revenue, 2024-2029
6.2.3 By Region - Global Protein Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Protein Drugs Revenue, 2018-2029
6.3.2 US Protein Drugs Market Size, 2018-2029
6.3.3 Canada Protein Drugs Market Size, 2018-2029
6.3.4 Mexico Protein Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Protein Drugs Revenue, 2018-2029
6.4.2 Germany Protein Drugs Market Size, 2018-2029
6.4.3 France Protein Drugs Market Size, 2018-2029
6.4.4 U.K. Protein Drugs Market Size, 2018-2029
6.4.5 Italy Protein Drugs Market Size, 2018-2029
6.4.6 Russia Protein Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Protein Drugs Market Size, 2018-2029
6.4.8 Benelux Protein Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Protein Drugs Revenue, 2018-2029
6.5.2 China Protein Drugs Market Size, 2018-2029
6.5.3 Japan Protein Drugs Market Size, 2018-2029
6.5.4 South Korea Protein Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Protein Drugs Market Size, 2018-2029
6.5.6 India Protein Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Protein Drugs Revenue, 2018-2029
6.6.2 Brazil Protein Drugs Market Size, 2018-2029
6.6.3 Argentina Protein Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Protein Drugs Revenue, 2018-2029
6.7.2 Turkey Protein Drugs Market Size, 2018-2029
6.7.3 Israel Protein Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Protein Drugs Market Size, 2018-2029
6.7.5 UAE Protein Drugs Market Size, 2018-2029
7 Protein Drugs Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Protein Drugs Major Product Offerings
7.1.4 Eli Lilly Protein Drugs Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Protein Drugs Major Product Offerings
7.2.4 Abbott Laboratories Protein Drugs Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 UCB Group
7.3.1 UCB Group Company Summary
7.3.2 UCB Group Business Overview
7.3.3 UCB Group Protein Drugs Major Product Offerings
7.3.4 UCB Group Protein Drugs Revenue in Global Market (2018-2023)
7.3.5 UCB Group Key News & Latest Developments
7.4 Schering-Plough Corporation
7.4.1 Schering-Plough Corporation Company Summary
7.4.2 Schering-Plough Corporation Business Overview
7.4.3 Schering-Plough Corporation Protein Drugs Major Product Offerings
7.4.4 Schering-Plough Corporation Protein Drugs Revenue in Global Market (2018-2023)
7.4.5 Schering-Plough Corporation Key News & Latest Developments
7.5 Genentech
7.5.1 Genentech Company Summary
7.5.2 Genentech Business Overview
7.5.3 Genentech Protein Drugs Major Product Offerings
7.5.4 Genentech Protein Drugs Revenue in Global Market (2018-2023)
7.5.5 Genentech Key News & Latest Developments
7.6 Johnson?Johnson
7.6.1 Johnson?Johnson Company Summary
7.6.2 Johnson?Johnson Business Overview
7.6.3 Johnson?Johnson Protein Drugs Major Product Offerings
7.6.4 Johnson?Johnson Protein Drugs Revenue in Global Market (2018-2023)
7.6.5 Johnson?Johnson Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Protein Drugs Major Product Offerings
7.7.4 Bristol-Myers Squibb Protein Drugs Revenue in Global Market (2018-2023)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
7.8 Novo Nordisk
7.8.1 Novo Nordisk Company Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Protein Drugs Major Product Offerings
7.8.4 Novo Nordisk Protein Drugs Revenue in Global Market (2018-2023)
7.8.5 Novo Nordisk Key News & Latest Developments
7.9 Biogen Idec
7.9.1 Biogen Idec Company Summary
7.9.2 Biogen Idec Business Overview
7.9.3 Biogen Idec Protein Drugs Major Product Offerings
7.9.4 Biogen Idec Protein Drugs Revenue in Global Market (2018-2023)
7.9.5 Biogen Idec Key News & Latest Developments
7.10 Dendreon Corporation
7.10.1 Dendreon Corporation Company Summary
7.10.2 Dendreon Corporation Business Overview
7.10.3 Dendreon Corporation Protein Drugs Major Product Offerings
7.10.4 Dendreon Corporation Protein Drugs Revenue in Global Market (2018-2023)
7.10.5 Dendreon Corporation Key News & Latest Developments
7.11 Amgen Inc.
7.11.1 Amgen Inc. Company Summary
7.11.2 Amgen Inc. Business Overview
7.11.3 Amgen Inc. Protein Drugs Major Product Offerings
7.11.4 Amgen Inc. Protein Drugs Revenue in Global Market (2018-2023)
7.11.5 Amgen Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Protein Drugs Market Opportunities & Trends in Global Market
Table 2. Protein Drugs Market Drivers in Global Market
Table 3. Protein Drugs Market Restraints in Global Market
Table 4. Key Players of Protein Drugs in Global Market
Table 5. Top Protein Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Protein Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Protein Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Protein Drugs Product Type
Table 9. List of Global Tier 1 Protein Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Protein Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Protein Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Protein Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Protein Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Protein Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Protein Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Protein Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Eli Lilly Company Summary
Table 31. Eli Lilly Protein Drugs Product Offerings
Table 32. Eli Lilly Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly Key News & Latest Developments
Table 34. Abbott Laboratories Company Summary
Table 35. Abbott Laboratories Protein Drugs Product Offerings
Table 36. Abbott Laboratories Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. UCB Group Company Summary
Table 39. UCB Group Protein Drugs Product Offerings
Table 40. UCB Group Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. UCB Group Key News & Latest Developments
Table 42. Schering-Plough Corporation Company Summary
Table 43. Schering-Plough Corporation Protein Drugs Product Offerings
Table 44. Schering-Plough Corporation Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Schering-Plough Corporation Key News & Latest Developments
Table 46. Genentech Company Summary
Table 47. Genentech Protein Drugs Product Offerings
Table 48. Genentech Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Genentech Key News & Latest Developments
Table 50. Johnson?Johnson Company Summary
Table 51. Johnson?Johnson Protein Drugs Product Offerings
Table 52. Johnson?Johnson Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson?Johnson Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Summary
Table 55. Bristol-Myers Squibb Protein Drugs Product Offerings
Table 56. Bristol-Myers Squibb Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Bristol-Myers Squibb Key News & Latest Developments
Table 58. Novo Nordisk Company Summary
Table 59. Novo Nordisk Protein Drugs Product Offerings
Table 60. Novo Nordisk Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Novo Nordisk Key News & Latest Developments
Table 62. Biogen Idec Company Summary
Table 63. Biogen Idec Protein Drugs Product Offerings
Table 64. Biogen Idec Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Biogen Idec Key News & Latest Developments
Table 66. Dendreon Corporation Company Summary
Table 67. Dendreon Corporation Protein Drugs Product Offerings
Table 68. Dendreon Corporation Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Dendreon Corporation Key News & Latest Developments
Table 70. Amgen Inc. Company Summary
Table 71. Amgen Inc. Protein Drugs Product Offerings
Table 72. Amgen Inc. Protein Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Amgen Inc. Key News & Latest Developments
List of Figures
Figure 1. Protein Drugs Segment by Type in 2022
Figure 2. Protein Drugs Segment by Application in 2022
Figure 3. Global Protein Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Protein Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Protein Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Protein Drugs Revenue in 2022
Figure 8. By Type - Global Protein Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Protein Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Protein Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Protein Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Protein Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Protein Drugs Revenue Market Share, 2018-2029
Figure 16. US Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Protein Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Protein Drugs Revenue Market Share, 2018-2029
Figure 28. China Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Protein Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Protein Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Eli Lilly Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Laboratories Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. UCB Group Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Schering-Plough Corporation Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Genentech Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson?Johnson Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bristol-Myers Squibb Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novo Nordisk Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Biogen Idec Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Dendreon Corporation Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Amgen Inc. Protein Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
